Hetero acquires Spain-based Tarbis Farma

Drug firm Hetero Wednesday said its European subsidiary Amarox has acquired Spain-based Tarbis Farma from Grupo Ferrer Internacional for an undisclosed amount.

Commenting on the development, Hetero Labs Executive Director A V Narasa Reddy said: "This acquisition fits well with Hetero's growth strategy in EU giving Amarox a platform to reach out to the customers in a robust way with the present portfolio and Hetero's pipeline of products."